Literature DB >> 9647413

Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis.

A Enbergs1, A Dorszewski, M Luft, G Mönnig, A Kleemann, H Schulte, G Assmann, G Breithardt, S Kerber.   

Abstract

BACKGROUND: It has been suggested that iron overload, as assessed by increased serum ferritin concentration, may be a risk factor for coronary artery disease (CAD). Recent studies have reported conflicting data on the role of ferritin and other parameters of oxidative metabolism in CAD.
OBJECTIVE: The aim of this study was to assess the relation between the extent of CAD and parameters of oxidation.
METHODS: We studied 275 patients (208 men aged 55.1 +/- 9.6 years and 67 women aged 54.6 +/- 10.0 years) who underwent coronary angiography or percutaneous transluminal coronary angioplasty for the first time. The parameters assessed were: iron, ferritin, transferrin, copper, caeruloplasmin and lipid. Cinefilms were assessed by the use of three scores: (1) Vessel score: 0-3 points; 1 point for each of the three main coronary arteries with a stenosis >70%. (2) Stenosis score: 0-32 points; the coronary artery tree was divided into eight segments that were scored 1-4 points per segment with respect to the maximal degree of stenosis. (3) Extent score: 0-100 points; extent of diffuse coronary lesions in each segment in relation to the length of the vessel. Multiple regression analyses were used to evaluate the results.
RESULTS: Total cholesterol and low-density lipoprotein cholesterol (P < 0.001) in women, low-density lipoprotein cholesterol (P < 0.05) in men, and patient age showed a significant correlation with all three scores, but none of the parameters of oxidative metabolism (iron, transferrin, ferritin, copper, caeruloplasmin) correlated significantly with any of the three scores.
CONCLUSION: This study demonstrated a correlation between lipoproteins and the angiographic extent of CAD, but did not confirm a role for serum ferritin and other oxidative parameters as risk factors for the extent of CAD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647413

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Authors:  Ayşe Yeşim Göçmen; Emel Sahin; Ender Semiz; Saadet Gümuşlü
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

Review 2.  Iron: protector or risk factor for cardiovascular disease? Still controversial.

Authors:  Carlos Muñoz-Bravo; Mario Gutiérrez-Bedmar; Jorge Gómez-Aracena; Antonio García-Rodríguez; Joaquín Fernández-Crehuet Navajas
Journal:  Nutrients       Date:  2013-07-01       Impact factor: 5.717

3.  The association between fasting serum insulin, apo-lipoproteins level, and severity of coronary artery involvement in non-diabetic patients.

Authors:  Jafar Golshahi; Ebrahim Validi; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2014-09-12

Review 4.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

5.  Ceruloplasmin and the extent of heart failure in ischemic and nonischemic cardiomyopathy patients.

Authors:  Yifei Xu; Haiyan Lin; Ying Zhou; Gang Cheng; Geng Xu
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

6.  Ceruloplasmin and Coronary Heart Disease-A Systematic Review.

Authors:  Antonio P Arenas de Larriva; Laura Limia-Pérez; Juan F Alcalá-Díaz; Alvaro Alonso; José López-Miranda; Javier Delgado-Lista
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.